0.00Open0.00Pre Close0 Volume0 Open Interest23.00Strike Price0.00Turnover0.00%IV-77.67%PremiumNov 15, 2024Expiry Date10.06Intrinsic Value100Multiplier9DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.29Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Elanco Animal Health Stock Discussion
3 mins ago
Elanco Receives FDA Approval for Credelio Quattro™ (Lotilaner, Moxidectin, Praziquantel, and Pyrantel Chewable Tablets), the Broadest(I) Canine Oral Parasiticide Protection in a Single Monthly Dose
No comment yet